CoreWeave (CRWV) shares collapsed with investors expressing concerns on the company's "show me" story. Meghan Joyce presents a bull case in its backlog but a bear case in the construction needed to obtain that revenue. Logan Gilland adds to Meghan's points by saying he would not "buy into the blood" in CoreWeave's selling action. He says investors should wait to see who wins "the race to be first" in capitalizing on CapEx.